Alabama · 2026 Regular Session · Resolution

HR 166: Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

In committee Last action February 24, 2026: Read for the first time and referred to the House Committee on Rules

Plain-language summary

HR 166 is a resolution introduced in the Alabama House on February 24, 2026. According to its official title, it concerns: Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings. Primary sponsor: Ed Oliver (Republican). Most recent recorded action (February 24, 2026): Read for the first time and referred to the House Committee on Rules.

Sponsors

Primary sponsor: Ed Oliver (Republican).